13th Annual Fall Midwest Thoracic and GI Oncology Conference


 

Immunotherapy in Early Stage NSCLC and PACIFIC Trial of Durvalumab in Stage III Unresectable NSCLC

512 views
December 19, 2018
0 Comments
Login to view comments. Click here to Login